The Synergistic Effects of Rhamnolipids and Antibiotics Against Bacteria

Abstract

Antibiotics are used to combat bacterial infections by slowing down and preventing the proliferation of bacteria. Antibiotic resistance is a threat to human health, attributed to its overuse and misuse. Altering the membrane permeability to induce antibiotic uptake may be an effective strategy used against both Gram-positive and Gram-negative infectious bacteria. Rhamnolipids (RLs) are biosurfactants produced by Pseudomonas aeruginosa. RLs surface-active properties operate by creating holes in bacterial cell membranes, increasing target cell permeability; allowing antibiotics to penetrate the cell. 

Rhamnolipids enhance the effect of antibiotics by targeting the intracellular machinery of bacteria. This project tested the susceptibility of bacteria when exposed to antibiotics with and without the addition of RLs, to quantitatively determine if RLs increase antibiotic potency. By analyzing the zones of inhibition data, the results demonstrated that RLs potentiated the antibiotics. Notably, kanamycin coupled with RLs had the most effect inhibiting bacterial growth. 

To further assess rhamnolipid biosynthesis, a BLAST search was performed exclusively on two genes, rhlA and rhlB. These genes code for the production of two proteins necessary for rhamnolipids. The search indicated a 48% correlation with putative proteins found in Burkholderia pseudomallei. Therefore, based on the experimental results and the BLAST analysis, further research should be conducted to explore the possible role of using rhamnolipids as antibiotic enhancers. Specifically, future experiments could focus on isolating the putative proteins of B.pseudomallei to genetically modify E.coli. Furthermore, isolated studies analyzing the genes of proteins to determine their role in the pathogenicity of Burkholderia species.